IMMUNE DESIGN CORP.

Profile

Company Names

IMMUNE DESIGN CORP.

Addresses

1616 EASTLAKE AVE. E, SUITE 310, SEATTLE, WA 98102

1124 COLUMBIA ST, SUITE 700, SEATTLE, WA 98104

Phone Numbers

(206) 682-0645

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$96,502,510.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2013-10-16 
$48,450,000.00 
$57,750,000.00 
$9,300,000.00 
Equity 
7
2011-03-10 
$17,500.00 
$17,500.00 
$0.00 
Equity 
6
2010-07-23 
$34,000,000.00 
$34,000,000.00 
$0.00 
Equity 
5
2010-07-21 
$10,500.00 
$10,500.00 
$0.00 
Equity 
4
2009-09-22 
$10,500.00 
$10,500.00 
$0.00 
Equity 
3
2009-07-16 
$14,000.00 
$14,000.00 
$0.00 
Equity 
2
2008-06-05 
$14,000,000.00 
$18,000,000.00 
$4,000,000.00 
Equity 
1
2008-02-20 
$10.00 
$10.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
ATWOOD 
DIRECTOR
IMMUNE DESIGN CORP.   |  VERACYTE, INC.   |  MIRINA CORP   |  FIVE PRIME THERAPEUTICS INC   |  GROOVE BIOPHARMA CORP   |  PHASERX, INC.   |  ATRECA, INC.   |  CELL DESIGN LABS, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
BRIAN 
V 
ATWOOD 
DIRECTOR
IMMUNE DESIGN CORP.
DAVID 
 
BALTIMORE 
DIRECTOR
IMMUNE DESIGN CORP.   |  REGULUS THERAPEUTICS INC.   |  AMGEN INC   |  NANOMEDIX INC.
DAVID 
V 
BALTIMORE 
DIRECTOR
IMMUNE DESIGN CORP.
FRANKLIN 
 
BERGER 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  ITHERX PHARMA, INC.   |  IMMUNE DESIGN CORP.   |  ALZHEON, INC.   |  ATRECA, INC.   |  ESSA PHARMA INC.   |  CERUS ENDOVASCULAR LTD   |  KEZAR LIFE SCIENCES, INC.   |  BELLUS HEALTH INC.   |  APPLIED THERAPEUTICS INC.   |  ATEA PHARMACEUTICALS, INC.   |  RAIN THERAPEUTICS INC.   |  WALKING FISH THERAPEUTICS, INC.   |  SATELLOS BIOSCIENCE INC.
STEPHEN 
R 
BRADY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
STEPHEN 
R. 
BRADY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.   |  TEMPEST THERAPEUTICS, INC.
BRUCE 
 
CARTER 
EXECUTIVE OFFICER, DIRECTOR
MOKSHA8 INC   |  IMMUNE DESIGN CORP.   |  BANK OF QUEENSLAND LTD.
BRUCE 
LA 
CARTER 
DIRECTOR
IMMUNE DESIGN CORP.
BRUCE 
V 
CARTER 
DIRECTOR
IMMUNE DESIGN CORP.
THOMAS 
 
DUBENSKY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
SAMMY 
 
FARAH 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.   |  TURNSTONE BIOLOGICS CORP.
WAYNE 
 
GOMBOTZ 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
RICHARD 
T 
KENNEY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
RICHARD 
T. 
KENNEY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
RICHARD 
 
KLAUSNER 
DIRECTOR
IMMUNE DESIGN CORP.   |  JUNO THERAPEUTICS, INC.   |  GRAIL, INC.   |  MINDSTRONG, INC.   |  LIFEMINE THERAPEUTICS, INC.   |  MEDICAL CREATIONS, INC.   |  LYELL IMMUNOPHARMA, INC.   |  SONOMA BIOTHERAPEUTICS, INC.
DAVID 
 
PARKER 
EXECUTIVE OFFICER
VICTORY PHARMA INC   |  BLUE FROG GAMING INC   |  IMMUNE DESIGN CORP.   |  CARGURUS LLC   |  VITRIFLEX, INC.   |  ANKAA CORP.   |  ECULLET INC   |  TIPPT MEDIA, INC.   |  HONEST COMPANY, INC.   |  IDM MINING LTD.   |  LIAISON TECHNOLOGIES, INC.   |  COFFEE APPLICATIONS INC.   |  GOLDCUP 12446 AB   |  CARGURUS, INC.   |  DETECH ACQUISITION CO.   |  A-SYNAPTIC CORP.
CARLOS 
V 
PAYA 
EXECUTIVE OFFICER, DIRECTOR
IMMUNE DESIGN CORP.
CARLOS 
V. 
PAYA 
EXECUTIVE OFFICER, DIRECTOR
IMMUNE DESIGN CORP.
ED 
 
PENHOET 
DIRECTOR
IMMUNE DESIGN CORP.   |  SCYNEXIS INC   |  ATYR PHARMA INC
ED 
V 
PENHOET 
DIRECTOR
IMMUNE DESIGN CORP.
EDWARD 
 
PENHOET 
DIRECTOR
METABOLEX, INC.   |  IMMUNE DESIGN CORP.
ROGER 
 
PERLMUTTER 
DIRECTOR
IMMUNE DESIGN CORP.   |  EXONICS THERAPEUTICS, INC.
STEVE 
 
REED 
EXECUTIVE OFFICER, DIRECTOR
IMMUNE DESIGN CORP.
STEVEN 
 
REED 
EXECUTIVE OFFICER, DIRECTOR
IMMUNE DESIGN CORP.   |  BRIGHTSPRING HEALTH SERVICES, INC.   |  HORIZON BANCORP INC /IN/
STEVEN 
G. 
REED 
EXECUTIVE OFFICER, DIRECTOR
IMMUNE DESIGN CORP.
JAMES 
 
RICKEY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
JAMES 
PAUL 
RICKEY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.   |  SOUND PHARMACEUTICALS INC   |  ALPINE IMMUNE SCIENCES, INC.
PAUL 
 
RICKEY 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
WILLIAM 
 
RINGO 
DIRECTOR
ALVINE PHARMACEUTICALS INC   |  AGENEBIO, INC.   |  IMMUNE DESIGN CORP.   |  KOVINA THERAPEUTICS INC.
ALAIN 
 
SCHREIBER 
DIRECTOR
AEROVANCE INC   |  LEAD THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  ANAMETRIX, INC.   |  TRAGARA PHARMACEUTICALS, INC.   |  REVISION OPTICS INC   |  ADASTRA PHARMACEUTICALS, INC.
ALAIN 
V 
SCHREIBER 
DIRECTOR
IMMUNE DESIGN CORP.
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
PETER 
V 
SVENNILSON 
DIRECTOR
IMMUNE DESIGN CORP.
JAN HENRIK 
 
TER MEULEN 
EXECUTIVE OFFICER
IMMUNE DESIGN CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-06-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-03-10 
2014-06-11
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-07-21 
2014-06-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2008-02-20 
2013-10-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-16 
2013-01-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-23 
2011-10-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-23 
2010-08-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-23 
2010-08-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-23 
2009-10-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-07-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-16 
2009-07-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-06-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#